Results 261 to 270 of about 95,044 (332)

Nutritional Composition, Phytochemical Profile, Extraction Methods of Bioactive Components, and Health Benefits of Terminalia Arjuna Bark

eFood, Volume 6, Issue 2, April 2025.
The plant's bark is rich in polyphenols, particularly gallic acid and ellagic acid derivatives, which are powerful antioxidants. These antioxidants can protect cells from oxidative stress and may help prevent degenerative diseases. Additionally, Terminalia arjuna contains triterpenoids like arjunolic acid and arjunic acid, which have various ...
Hafsa Tahir, Muhammad Nadeem Akhtar, Ashok Kumar Bishoyi, Gaurav Sanghvi, Musarrat Rasheed, Muhammad Afzaal, Ali Imran, Farhan Saeed, Neeraj Khare, Faiyaz Ahmed, Oshin Sahni, Huda Ateeq, Fakhar Islam, Abdela Befa Kinki   +13 more
wiley   +1 more source

Improved Survival in Patients with Idiopathic Pulmonary Fibrosis Hospitalized for Acute Exacerbation. [PDF]

J Clin Med
Lionello F, Arcaro G, Bertagna De Marchi L, Braccioni F, Achille A, Lococo S, Ciresi M, Guarnieri G, Vianello A.   +8 more
europepmc   +1 more source

Gut microbiota‐related modulation of immune mechanisms in post‐infarction remodelling and heart failure

ESC Heart Failure, Volume 12, Issue 2, Page 942-954, April 2025.
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler, Friederike Zimmermann, Bettina Heidecker, Ulf Landmesser, Arash Haghikia   +4 more
wiley   +1 more source

Sputum matrix metalloproteinase-9, tissue inhibitor of metalloprotinease-1, and their molar ratio in patients with chronic obstructive pulmonary disease, idiopathic pulmonary fibrosis and healthy subjects

, 2003
Kai Michael Beeh, Jutta Beier, Oliver Kornmann, Roland Buhl   +3 more
openalex   +1 more source

Association of tracheal diameter with respiratory function and fibrosis severity in idiopathic pulmonary fibrosis patients. [PDF]

BMC Pulm Med
Fazlıoğlu N, Sasani H, Fazlıoğlu M, Çiftçi EP, Mutlu LC.   +4 more
europepmc   +1 more source

Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy

ESC Heart Failure, Volume 12, Issue 2, Page 1029-1044, April 2025.
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo, Tor Biering‐Sorensen, Joao P. Ferreira, Carlo Mario Lombardi, Andrea Bonelli, Andrea Garascia, Marco Metra, Riccardo M. Inciardi   +7 more
wiley   +1 more source

Quality of life in idiopathic pulmonary fibrosis in Latin American countries. [PDF]

BMC Pulm Med
Aguilar-Duran H, Fernández M, González-García M, Rincón-Alvarez E, Alberti M, Caro F, Tavera E, Vásquez E, Cortez N, Salinas M, Florenzano M, Florestano C, Buendia-Roldan I.   +12 more
europepmc   +1 more source

The effects of sodium–glucose cotransporter 2 inhibitors on the ‘forgotten’ right ventricle

ESC Heart Failure, Volume 12, Issue 2, Page 1045-1058, April 2025.
Abstract With the progress in diagnosis, treatment and imaging techniques, there is a growing recognition that impaired right ventricular (RV) function profoundly affects the prognosis of patients with heart failure (HF), irrespective of their left ventricular ejection fraction (LVEF).
Liangzhen Qu, Xueting Duan, Han Chen
wiley   +1 more source

Acute Exacerbation of Idiopathic Pulmonary Fibrosis in the Setting of Acute Eosinophilic Pneumonia. [PDF]

HCA Healthc J Med
McKinney DA, Kosnik NR, Syed S, Junko G.
europepmc   +1 more source